Alam Kamran — SEC Form 4 filings
SEC reporting owner CIK 1793412. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-06.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-06 to 2026-02-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 158,963 shares, $647,822 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 78,968 shares @ $4.75 ($375,098) in Taysha Gene Therapies, Inc., filed 2026-01-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | CHIEF FINANCIAL OFFICER | 8 | — | 4 legs · 158,963 sh · $647,822 | 7 |
Form 4 filings — Alam Kamran
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-06 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Sale (S): 1,655 @ $4.52 | EDGAR |
| 2026-01-27 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Sale (S): 78,968 @ $4.75 · Sale (S): 23,849 @ $4.61 | EDGAR |
| 2026-01-14 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Grant/award (A): 359,000 @ $0 · Grant/award (A): 231,000 (derivative) @ $0 | EDGAR |
| 2025-08-22 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Sale (S): 54,491 @ $2.85 | EDGAR |
| 2025-04-10 | 4/A | Taysha Gene Therapies, Inc. (TSHA) | Grant/award (A): 12,462 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Tax withholding (F): 29,843 @ $1.69 | EDGAR |
| 2025-01-03 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Grant/award (A): 431,000 @ $0 · Grant/award (A): 431,000 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Tax withholding (F): 1,288 @ $1.51 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1793412 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →